科学や哲学から遠く離れている.

Same author

Predictors of mortality in individuals with disseminated histoplasmosis and advanced HIV disease.

Medical mycology·2026

Same author

Predictors of mortality among individuals with advanced HIV disease in a contemporary Brazilian cohort.

Revista panamericana de salud publica = Pan American journal of public health·2026

Same author

New 2030 Global Targets for Histoplasmosis from International Society for Human and Animal Mycology (ISHAM) 2025 Histoplasmosis Working Group.

Emerging infectious diseases·2026

Same author

Use of DOOR and Win-Ratio Analysis in a Secondary Evaluation of a Histoplasmosis Clinical Trial.

Open forum infectious diseases·2026

Same author

Histoplasmosis: a missing piece in the global efforts to end HIV deaths.

The lancet. HIV·2026

Same author

Fungal meningoencephalitis caused by <i>Phanerochaete</i> sp.: Case report.

Medical mycology case reports·2026

Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026

Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026

Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026

Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026

Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026

Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026

関連する実験動画

科学や哲学から遠く離れている.

関連する概念動画

Predictors of mortality in individuals with disseminated histoplasmosis and advanced HIV disease.

Predictors of mortality among individuals with advanced HIV disease in a contemporary Brazilian cohort.

New 2030 Global Targets for Histoplasmosis from International Society for Human and Animal Mycology (ISHAM) 2025 Histoplasmosis Working Group.

Use of DOOR and Win-Ratio Analysis in a Secondary Evaluation of a Histoplasmosis Clinical Trial.

Histoplasmosis: a missing piece in the global efforts to end HIV deaths.

Fungal meningoencephalitis caused by <i>Phanerochaete</i> sp.: Case report.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

関連する実験動画

科学や哲学から遠く離れている.

関連する概念動画

関連記事

Predictors of mortality in individuals with disseminated histoplasmosis and advanced HIV disease.

Predictors of mortality among individuals with advanced HIV disease in a contemporary Brazilian cohort.

New 2030 Global Targets for Histoplasmosis from International Society for Human and Animal Mycology (ISHAM) 2025 Histoplasmosis Working Group.

Use of DOOR and Win-Ratio Analysis in a Secondary Evaluation of a Histoplasmosis Clinical Trial.

Histoplasmosis: a missing piece in the global efforts to end HIV deaths.

Fungal meningoencephalitis caused by <i>Phanerochaete</i> sp.: Case report.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.